As mentioned above, SARS-CoV2 can enter and infect the host pulmonary cells using the angiotensin-converting enzyme ACE2 receptor expressed in the membrane of pulmonary cells, therefore it has been suggested that ACE inhibitors and angiotensin-receptor blockers could negatively or positively interfere with the viral infection process [118,119]. The gene discussed is ACE; the disease is viral infectious disease.